Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Troughton

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Journal of the American College of Cardiology|April 9, 2013
Fine tuning risk stratification for atrial fibrillationRichard W Troughton, Ian Crozier
European Journal of Heart Failure|February 28, 2004
NT-proBNP in heart failure: therapy decisions and monitoringMark Richards, Richard W Troughton
Heart Failure Clinics|March 28, 2007
BNP for clinical monitoring of heart failureRichard W Troughton, A Mark Richards
Current Treatment Options in Cardiovascular Medicine|January 29, 2008
Management of constrictive pericarditis in the 21st centuryGeoffrey C Clare, Richard W Troughton
Clinical Chemistry|November 17, 2011
Use of natriuretic peptides to guide and monitor heart failure therapyA Mark Richards, Richard W Troughton
European Journal of Heart Failure|August 30, 2011
B-type natriuretic peptide or amino-terminal pro-B-type natriuretic peptide-guided treatment of heart failure: what is the next STEP?Richard W Troughton, M Gary Nicholls
European Journal of Heart Failure|March 26, 2010
Improving risk stratification in heart failure: a role for new biomarkers?Timothy G Yandle, Richard W Troughton
The American Journal of Cardiology|February 22, 2008
Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurementRichard W Troughton, A Mark Richards
JACC. Cardiovascular Imaging|April 10, 2009
B-type natriuretic peptides and echocardiographic measures of cardiac structure and functionRichard W Troughton, A Mark Richards
Journal of the American College of Cardiology|February 2, 2018
Can Biomarker Panels Predict Response to Pharmacotherapy in Heart Failure?Richard W Troughton, Christopher M A Frampton
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Journal of the American College of Cardiology|April 9, 2013
Fine tuning risk stratification for atrial fibrillationRichard W Troughton, Ian Crozier
European Journal of Heart Failure|February 28, 2004
NT-proBNP in heart failure: therapy decisions and monitoringMark Richards, Richard W Troughton
Heart Failure Clinics|March 28, 2007
BNP for clinical monitoring of heart failureRichard W Troughton, A Mark Richards
Current Treatment Options in Cardiovascular Medicine|January 29, 2008
Management of constrictive pericarditis in the 21st centuryGeoffrey C Clare, Richard W Troughton
Clinical Chemistry|November 17, 2011
Use of natriuretic peptides to guide and monitor heart failure therapyA Mark Richards, Richard W Troughton
European Journal of Heart Failure|August 30, 2011
B-type natriuretic peptide or amino-terminal pro-B-type natriuretic peptide-guided treatment of heart failure: what is the next STEP?Richard W Troughton, M Gary Nicholls
European Journal of Heart Failure|March 26, 2010
Improving risk stratification in heart failure: a role for new biomarkers?Timothy G Yandle, Richard W Troughton
The American Journal of Cardiology|February 22, 2008
Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurementRichard W Troughton, A Mark Richards
JACC. Cardiovascular Imaging|April 10, 2009
B-type natriuretic peptides and echocardiographic measures of cardiac structure and functionRichard W Troughton, A Mark Richards
Journal of the American College of Cardiology|February 2, 2018
Can Biomarker Panels Predict Response to Pharmacotherapy in Heart Failure?Richard W Troughton, Christopher M A Frampton
Pageof 17